Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
2 employees
LSAN: A New York-based angel network, providing funding and operational support to early-stage life sciences companies.
HQ
Founded
2010
Life Sciences Angel Network (LSAN) is a New York-based organization dedicated to funding and supporting early-stage life sciences companies. Founded in 2010 by Dr. Milena Adamian, LSAN identifies promising startups in the life sciences sector and provides them with essential financial and operational resources to foster growth. Initially operating under the New York Academy of Sciences, LSAN became an independent entity in early 2012, focusing on bridging the gap for innovative life sciences ventures in New York.
Since its inception, LSAN has made significant strides in the life sciences investment community. The network has successfully supported numerous startups, contributing to advancements in medical technology and healthcare solutions. By leveraging its extensive network of industry experts and investors, LSAN has created a robust ecosystem that nurtures innovation and accelerates the development of groundbreaking life sciences companies.
Operating Status
Active
Ownership Type(s)
Angel
Main Product(s)
Support, Funding
Technology
Life Sciences
Tags
Biotech
Model Types
Platform
Revenue Type(s)
Financial
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Life Sciences Angel Network founded?
Life Sciences Angel Network was founded in 2010.
Where is Life Sciences Angel Network's headquarters located?
Life Sciences Angel Network's headquarters is located in New York City, NY, US.
How many employees does Life Sciences Angel Network have?
Life Sciences Angel Network has 2 employees as of Feb 4, 2024.
Add Comparison
Current Employees
2
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts